Table of Studies for [insert Brand Name of drug] Study Start & End Sponsor Description Phase Abstracts, Publications and Errata ID(s) Date List of all pivotal for the indication(s) to be reviewed by CADTH 1. Citation #1 Title: Start: MM/YYYY Study Design: double blind, placebo-controlled, multicentre RCT End: Randomized N: Total sample size MM/YYYY 2. Citation #2 Brief description Population: Intervention(s): Drug under review, dosage, administration *all citations must use the Citing Medicine frequency format Comparator(s): Comparator(s) dosage, administration frequency Outcomes: Primary and key secondary endpoints List of all additional completed RCTs for the indication(s) to be reviewed by CADTH Title: Start: 1. Citation #1 MM/YYYY Study Design: Brief description Randomized N: Total sample size End: Population: Brief description MM/YYYY 2. Citation #2 Intervention(s): Drug under review, dosage, administration *all citations must use the Citing Medicine frequency format Comparator(s) dosage, administration Comparator(s): frequency Outcomes: Primary and key secondary endpoints List of completed non-randomized studies for the indication(s) to be reviewed by CADTH 1. Citation #1 Title: Start: MM/YYYY Study Design: Brief description Total sample size: End: Brief description Population: MM/YYYY 2. Citation #2 Drug under review, dosage, administration Intervention(s): frequency *all citations must use the Citing Medicine format Comparator(s): Comparator(s) dosage, administration frequency Primary and key secondary endpoints Outcomes: List of all ongoing studies for the indication[s] to be reviewed by CADTH 2, 3 or Start: 1. Citation #1 Provide a brief description
Table of Studies for [insert Brand Name of drug] Study ID(s) Sponsor Description Phase Start & End Date Abstracts, Publications and Errata List of all pivotal for the indication(s) to be reviewed by CADTH Title: Study Design: double blind, placebo-controlled, multicentre RCT Randomized N: Total sample size Population: Brief description Intervention(s): Drug under review, dosage, administration frequency Comparator(s): Comparator(s) dosage, administration frequency Outcomes: Primary and key secondary endpoints Start: MM/YYYY End: MM/YYYY 1. Citation #1 2. Citation #2 *all citations must use the Citing Medicine format List of all additional completed RCTs for the indication(s) to be reviewed by CADTH Title: Study Design: Brief description Randomized N: Total sample size Population: Brief description Intervention(s): Drug under review, dosage, administration frequency Comparator(s): Comparator(s) dosage, administration frequency Outcomes: Primary and key secondary endpoints Start: MM/YYYY End: MM/YYYY 1. Citation #1 2. Citation #2 *all citations must use the Citing Medicine format List of completed non-randomized studies for the indication(s) to be reviewed by CADTH Title: Study Design: Brief description Total sample size: Population: Brief description Intervention(s): Drug under review, dosage, administration frequency Comparator(s): Comparator(s) dosage, administration frequency Outcomes: Primary and key secondary endpoints Start: MM/YYYY End: MM/YYYY 1. Citation #1 2. Citation #2 *all citations must use the Citing Medicine format List of all ongoing studies for the indication[s] to be reviewed by CADTH Provide a brief description 2, 3 or Start: 1. Citation #1
Table_of_Studies_Template.docx